Emily Kramer-Golinkoff, a cystic fibrosis patient with a rare mutation, highlights the struggles of those left behind as gene therapies show promise for others. Her journey underscores the need for equitable treatments in rare genetic conditions.
A groundbreaking study reveals that a biologic drug may delay Alzheimer's symptoms in individuals with genetic predispositions. With promising results, researchers emphasize the importance of continued funding for further investigation.
